Target intelligence / Profile preview

Influenza matrix protein 1 (M1) (M1)

Target
M1
Molecular classification
Viral matrix protein, Structural protein, Other
01

Overview

Influenza matrix protein 1 (M1) is the most abundant structural protein of the influenza A virus, forming a continuous layer beneath the viral lipid envelope [1, 2]. It serves as a multifunctional adapter that orchestrates several critical stages of the viral lifecycle, including viral uncoating, genome transcription, nuclear export of viral ribonucleoproteins (vRNPs), and the assembly and budding of new virions [2, 3, 6]. M1 is highly conserved across different influenza A subtypes, making it a prime candidate for the development of universal vaccines and broad-spectrum antivirals that could overcome the resistance issues associated with current neuraminidase and M2 ion channel inhibitors [1, 20, 24]. Experimental small molecules, such as the "wedge" inhibitor PHE and the stabilizer M1m1, have demonstrated the potential to halt viral replication by interfering with M1's ability to self-associate or by blocking}

Other names
Matrix protein 1M1 proteinInfluenza A virus matrix protein 1Matrix protein M1
02

Mechanism of action

Inhibition of viral assembly and budding through disruption of M1 self-oligomerization; interference with the nuclear export of viral ribonucleoproteins (vRNPs); and stabilization of the M1 layer to prevent pH-dependent uncoating.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Functional complexity and structural plasticityPotential for off-target effects on host metabolic or immune pathwaysLack of high-resolution full-length structural data for precise drug design
06

Interacting drugs

PHE

1 more in the full profile.

07

Biomarkers

M1 58-66 epitope (GILGFVFTL)M1-specific CD8+ T-cell responseM1 protein levels

Beyond the preview

Go deeper on Influenza matrix protein 1 (M1) (M1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza matrix protein 1 (M1) (M1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call